Smart Polymeric Nanocarriers for Drug Delivery
暂无分享,去创建一个
María J. Vicent | M. Vicent | A. Duro-Castano | M. Talelli | G. Rodríguez-Escalona | Marina Talelli | Aroa Duro-Castano | G. Rodríguez-Escalona
[1] R. Duncan,et al. Bioresponsive dextrin-rhEGF conjugates: in vitro evaluation in models relevant to its proposed use as a treatment for chronic wounds. , 2010, Molecular pharmaceutics.
[2] Taryn R. Bagby,et al. Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[3] D. Iannitti,et al. Paclitaxel Poliglumex (PPX-Xyotax) and Concurrent Radiation for Esophageal and Gastric Cancer: A Phase I Study , 2006, American journal of clinical oncology.
[4] R. Duncan,et al. The effect of dextrin-rhEGF on the healing of full-thickness, excisional wounds in the (db/db) diabetic mouse. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[5] W. Pitt,et al. Ultrasonic-activated micellar drug delivery for cancer treatment. , 2009, Journal of pharmaceutical sciences.
[6] M. Vallet‐Regí,et al. Magnetically Triggered Multidrug Release by Hybrid Mesoporous Silica Nanoparticles , 2012 .
[7] María J. Vicent,et al. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. , 2009, Advanced drug delivery reviews.
[8] Elias Fattal,et al. Nanocapsule technology: a review. , 2002, Critical reviews in therapeutic drug carrier systems.
[9] Ashutosh Chilkoti,et al. Targeted drug delivery by thermally responsive polymers. , 2002, Advanced drug delivery reviews.
[10] G. Tiram,et al. Administration, distribution, metabolism and elimination of polymer therapeutics. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[11] R. Duncan,et al. Poly(amido‐amine)s: Biomedical Applications , 2002 .
[12] K. Ulbrich,et al. Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[13] M. Vicent,et al. Polymer-drug conjugates for novel molecular targets. , 2010, Nanomedicine.
[14] Emanuel Fleige,et al. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. , 2012, Advanced drug delivery reviews.
[15] N. Rapoport,et al. Mechanism of the ultrasonic activation of micellar drug delivery. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[16] L. Gerweck,et al. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. , 1996, Cancer research.
[17] H. Wang,et al. Cathepsin B may be a potential biomarker in cervical cancer. , 2012, Histology and histopathology.
[18] M. Stevens,et al. Engineering nanocomposite materials for cancer therapy. , 2010, Small.
[19] Robert Langer,et al. A magnetically triggered composite membrane for on-demand drug delivery. , 2009, Nano letters.
[20] F. Caruso,et al. Uptake and intracellular fate of disulfide-bonded polymer hydrogel capsules for Doxorubicin delivery to colorectal cancer cells. , 2010, ACS nano.
[21] J. Wiktorowicz,et al. Thiol‐reactive dyes for fluorescence labeling of proteomic samples , 2003, Electrophoresis.
[22] J. Burdick,et al. Light-responsive biomaterials: development and applications. , 2010, Macromolecular bioscience.
[23] J. Kopeček,et al. Synthesis of HPMA Copolymer Containing Adriamycin Bound via an Acid-Labile Spacer and its Activity toward Human Ovarian Carcinoma Cells , 1999 .
[24] Alexander V Kabanov,et al. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[25] J. Singer,et al. Synthesis and in Vivo Antitumor Activity of Poly(l-glutamic acid) Conjugates of 20(S)-Camptothecin , 2003 .
[26] S. Parveen,et al. Polymeric nanoparticles for cancer therapy , 2008, Journal of drug targeting.
[27] C. Bárcena,et al. APPLICATIONS OF MAGNETIC NANOPARTICLES IN BIOMEDICINE , 2003 .
[28] Omid C Farokhzad,et al. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. , 2012, Chemical Society reviews.
[29] W. Hennink,et al. Reduction-sensitive polymers and bioconjugates for biomedical applications. , 2009, Biomaterials.
[30] J. Karp,et al. Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .
[31] D. Kerr,et al. Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] T. Baker,et al. Controlling and switching the morphology of micellar nanoparticles with enzymes. , 2011, Journal of the American Chemical Society.
[33] K. Letchford,et al. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[34] B. Sumerlin,et al. Future perspectives and recent advances in stimuli-responsive materials , 2010 .
[35] Anna Moore,et al. Magnetic Nanoparticles for Cancer Diagnosis and Therapy , 2012, Pharmaceutical Research.
[36] Hong Wu,et al. Folate-decorated maleilated pullulan-doxorubicin conjugate for active tumor-targeted drug delivery. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[37] I. Mellman. Endocytosis and molecular sorting. , 1996, Annual review of cell and developmental biology.
[38] R. Haag,et al. Development of enzymatically cleavable prodrugs derived from dendritic polyglycerol. , 2009, Bioorganic & medicinal chemistry letters.
[39] H. Maeda. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[40] D. Schmaljohann. Thermo- and pH-responsive polymers in drug delivery. , 2006, Advanced drug delivery reviews.
[41] P. Ofek,et al. Targeting Angiogenesis-Dependent Calcified Neoplasms Using Combined Polymer Therapeutics , 2009, PloS one.
[42] Dai Fukumura,et al. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. , 2007, Microvascular research.
[43] R. Buckley,et al. HPMA Copolymers Platinates Containing Dicarboxylato Ligands. Preparation, Characterisation and In Vitro and In Vivo Evaluation , 2002, Journal of drug targeting.
[44] Jinming Hu,et al. Enzyme-responsive polymeric assemblies, nanoparticles and hydrogels. , 2012, Chemical Society reviews.
[45] R. Duncan,et al. Intracellular fate of bioresponsive poly(amidoamine)s in vitro and in vivo. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[46] R. Duncan,et al. Nanomedicine(s) under the microscope. , 2011, Molecular pharmaceutics.
[47] R. Langer,et al. Antitumor efficacy of a novel polymer–peptide–drug conjugate in human tumor xenograft models , 2006, International journal of cancer.
[48] J. Kopeček,et al. Polymers containing enzymatically degradable bonds, 7. Design of oligopeptide side-chains in poly[N-(2-hydroxypropyl)methacrylamide] copolymers to promote efficient degradation by lysosomal enzymes† , 1983 .
[49] S. Armes,et al. The facile one-pot synthesis of shell cross-linked micelles in aqueous solution at high solids. , 2001, Journal of the American Chemical Society.
[50] K. Ulbrich,et al. Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[51] E. Kumacheva,et al. Properties and emerging applications of self-assembled structures made from inorganic nanoparticles. , 2010, Nature nanotechnology.
[52] Giuseppe Battaglia,et al. Synthetic bio-nanoreactor: mechanical and chemical control of polymersome membrane permeability. , 2012, Angewandte Chemie.
[53] M. Stevens,et al. Enzyme‐Responsive Nanoparticle Systems , 2008 .
[54] K. Ulbrich,et al. Preclinical Evaluation of Linear HPMA-Doxorubicin Conjugates with pH-Sensitive Drug Release: Efficacy, Safety, and Immunomodulating Activity in Murine Model , 2009, Pharmaceutical Research.
[55] Felix Kratz,et al. Synthesis, Cleavage Profile, and Antitumor Efficacy of an Albumin‐Binding Prodrug of Methotrexate that is Cleaved by Plasmin and Cathepsin B , 2007, Archiv der Pharmazie.
[56] Eun Seong Lee,et al. Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH. , 2008, Small.
[57] J. Singer,et al. Water-soluble poly-(L-glutamic acid)-Gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivo. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[58] Wim E Hennink,et al. Poly(N-(2-hydroxypropyl) methacrylamide mono/di lactate): a new class of biodegradable polymers with tuneable thermosensitivity. , 2004, Biomacromolecules.
[59] C. van Nostrum,et al. Therapeutic Nanomedicine: Cross linked micelles with transiently linked drugs – a versatile drug delivery system , 2010 .
[60] R. Schweins,et al. Demonstrating the importance of polymer-conjugate conformation in solution on its therapeutic output: Diethylstilbestrol (DES)-polyacetals as prostate cancer treatment. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[61] K. Ulbrich,et al. The same drug but a different mechanism of action: comparison of free doxorubicin with two different N-(2-hydroxypropyl)methacrylamide copolymer-bound doxorubicin conjugates in EL-4 cancer cell line. , 2007, Bioconjugate chemistry.
[62] Z. Gan,et al. The influence of pendant hydroxyl groups on enzymatic degradation and drug delivery of amphiphilic poly[glycidol-block-(epsilon-caprolactone)] copolymers. , 2009, Macromolecular bioscience.
[63] R. Duncan. Polymer therapeutics as nanomedicines: new perspectives. , 2011, Current opinion in biotechnology.
[64] R. Mülhaupt,et al. Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution. , 1999, Bioorganic & medicinal chemistry.
[65] W. Meier,et al. Synthesis of Photocleavable Amphiphilic Block Copolymers: Toward the Design of Photosensitive Nanocarriers , 2010 .
[66] M. Vicent,et al. Polymer therapeutics-prospects for 21st century: the end of the beginning. , 2013, Advanced drug delivery reviews.
[67] K. Uhrich,et al. Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters). , 2000, Biomaterials.
[68] M. Vicent,et al. Polyacetal-stilbene conjugates - The first examples of polymer therapeutics for the inhibition of HIF-1 in the treatment of solid tumours. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[69] C. Alexander,et al. Stimuli responsive polymers for biomedical applications. , 2005, Chemical Society reviews.
[70] R. Mülhaupt,et al. Correlation of the acid-sensitivity of polyethylene glycol daunorubicin conjugates with their in vitro antiproliferative activity. , 2006, Bioorganic & medicinal chemistry.
[71] Adah Almutairi,et al. UV and near-IR triggered release from polymeric nanoparticles. , 2010, Journal of the American Chemical Society.
[72] K. Ulbrich,et al. HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[73] G. Kumar,et al. Photochemistry of azobenzene-containing polymers , 1989 .
[74] Wenming Liu,et al. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery. , 2011, Colloids and surfaces. B, Biointerfaces.
[75] Hua Wei,et al. Thermo-sensitive polymeric micelles based on poly(N-isopropylacrylamide) as drug carriers , 2009 .
[76] S. Hussain,et al. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging , 2001, European Radiology.
[77] B. Zhang,et al. Curcumin polymers as anticancer conjugates. , 2010, Biomaterials.
[78] R. Langer,et al. Synthesis and characterization of dextran-peptide-methotrexate conjugates for tumor targeting via mediation by matrix metalloproteinase II and matrix metalloproteinase IX. , 2004, Bioconjugate chemistry.
[79] C. Palivan,et al. Photoresponsive polymersomes as smart, triggerable nanocarriers , 2011 .
[80] D. Kerr,et al. Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. , 2009, International journal of oncology.
[81] Hui Zhao,et al. o-Nitrobenzyl Alcohol Derivatives: Opportunities in Polymer and Materials Science , 2012 .
[82] E. Pérez-Payá,et al. A Nanoconjugate Apaf-1 Inhibitor Protects Mesothelial Cells from Cytokine-Induced Injury , 2009, PloS one.
[83] Z. Gan,et al. Novel reduction-sensitive micelles for triggered intracellular drug release. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[84] Ruth Duncan,et al. Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt. , 2009, Advanced drug delivery reviews.
[85] K. Ulbrich,et al. HPMA copolymers containing doxorubicin bound by a proteolytically or hydrolytically cleavable bond: comparison of biological properties in vitro. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[86] Ruixue Liu,et al. Thermoresponsive copolymers: from fundamental studies to applications , 2009 .
[87] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[88] Guoyao Wu,et al. Glutathione metabolism and its implications for health. , 2004, The Journal of nutrition.
[89] H. Klok,et al. From supramolecular polymersomes to stimuli-responsive nano-capsules based on poly(diene-b-peptide) diblock copolymers , 2003, The European physical journal. E, Soft matter.
[90] J. Oh. Polylactide (PLA)-based amphiphilic block copolymers: synthesis, self-assembly, and biomedical applications , 2011 .
[91] Sudesh Kumar Yadav,et al. Biodegradable polymeric nanoparticles based drug delivery systems. , 2010, Colloids and surfaces. B, Biointerfaces.
[92] F. Kiessling,et al. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[93] Chun Xing Li,et al. Conjugation of Camptothecins to Poly‐(l‐Glutamic Acid) , 2000, Annals of the New York Academy of Sciences.
[94] Felix Kratz,et al. Polymer therapeutics: concepts and applications. , 2006, Angewandte Chemie.
[95] P. Marmottant,et al. Controlled vesicle deformation and lysis by single oscillating bubbles , 2003, Nature.
[96] T. Andresen,et al. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. , 2005, Progress in lipid research.
[97] Wim E Hennink,et al. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[98] P. Hunziker,et al. Designing switchable nanosystems for medical application. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[99] K. Anseth,et al. Poly(ethylene glycol) hydrogels formed by thiol-ene photopolymerization for enzyme-responsive protein delivery. , 2009, Biomaterials.
[100] C. Kumar,et al. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. , 2011, Advanced drug delivery reviews.
[101] Robert Langer,et al. Coiled‐Coil Peptide‐Based Assembly of Gold Nanoparticles , 2004 .
[102] Yue Zhao,et al. How can azobenzene block copolymer vesicles be dissociated and reformed by light? , 2005, The journal of physical chemistry. B.
[103] Yue Zhao,et al. Preparation of Azobenzene-Containing Amphiphilic Diblock Copolymers for Light-Responsive Micellar Aggregates , 2004 .
[104] Frank Bates,et al. Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation. , 2006, Molecular pharmaceutics.
[105] S. Brocchini,et al. Pendent Chain Functionalized Polyacetals That Display pH-Dependent Degradation: A Platform for the Development of Novel Polymer Therapeutics , 2002 .
[106] R. Duncan,et al. HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity in vivo. , 1999, European journal of cancer.
[107] Ruth Duncan,et al. Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation , 2004, Nature Biotechnology.
[108] R. Langer,et al. Poly(Ethylene Oxide)-Modified Poly(β-Amino Ester) Nanoparticles as a pH-Sensitive System for Tumor-Targeted Delivery of Hydrophobic Drugs: Part 2. In Vivo Distribution and Tumor Localization Studies , 2005, Pharmaceutical Research.
[109] Igor L. Medintz,et al. Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.
[110] J. Heller,et al. Preparation of polyacetals by the reaction of divinyl ethers and polyols , 1980 .
[111] María J Vicent,et al. Polymer therapeutics: clinical applications and challenges for development. , 2009, Advanced drug delivery reviews.
[112] R. Duncan. The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.
[113] Zhen Gu,et al. Redox-responsive nanocapsules for intracellular protein delivery. , 2011, Biomaterials.
[114] M. Ranson,et al. A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction , 2011, Investigational New Drugs.
[115] L. Murray,et al. Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[116] W. Hennink,et al. Thermosensitive polymeric micelles for targeted drug delivery. , 2011, Nanomedicine.
[117] D. Speicher,et al. IL8 and Cathepsin B as Melanoma Serum Biomarkers , 2011, International journal of molecular sciences.
[118] J. Kost,et al. Ultrasonically controlled polymeric drug delivery , 1988 .
[119] M. Vicent,et al. Polymer--drug conjugates as nano-sized medicines. , 2011, Current opinion in biotechnology.
[120] S. Brocchini,et al. Polyacetal-diethylstilboestrol: A Polymeric Drug Designed for pH-triggered Activation , 2004, Journal of drug targeting.
[121] C. van Nostrum,et al. Physicochemical characterization of degradable thermosensitive polymeric micelles. , 2004, Langmuir : the ACS journal of surfaces and colloids.
[122] P. Schwille,et al. Photo-crosslinked and pH sensitive polymersomes for triggering the loading and release of cargo. , 2011, Chemical communications.
[123] A. Hoffman,et al. pH-sensitive polymers that enhance intracellular drug delivery in vivo. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[124] Alexander V Kabanov,et al. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[125] S. Ganta,et al. A review of stimuli-responsive nanocarriers for drug and gene delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[126] Yue Zhao,et al. Light-Responsive Block Copolymer Micelles , 2012 .
[127] Y. Shaked,et al. Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances. , 2011, Biomaterials.
[128] C. van Nostrum,et al. Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies. , 2007, Biomaterials.
[129] R. Langer,et al. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model , 2007, Cancer Chemotherapy and Pharmacology.
[130] María J Vicent,et al. Polymer therapeutics designed for a combination therapy of hormone-dependent cancer. , 2005, Angewandte Chemie.
[131] Molly M Stevens,et al. Enzyme-responsive nanoparticles for drug release and diagnostics. , 2012, Advanced drug delivery reviews.
[132] T Lammers,et al. Tumour-targeted nanomedicines: principles and practice , 2008, British Journal of Cancer.
[133] Mischa Zelzer,et al. Next-generation peptide nanomaterials: molecular networks, interfaces and supramolecular functionality. , 2010, Chemical Society reviews.
[134] S. Brocchini,et al. Polyacetal-doxorubicin conjugates designed for pH-dependent degradation. , 2003, Bioconjugate chemistry.
[135] Wenying Zhou,et al. Ultrasound-triggered drug release and enhanced anticancer effect of doxorubicin-loaded poly(D,L-lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanodroplets. , 2011, Ultrasound in medicine & biology.
[136] J. Double,et al. Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor models with differing responses to PK1. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[137] R. Duncan,et al. Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[138] Jun Wang,et al. Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells. , 2011, Bioconjugate chemistry.
[139] K. Ulbrich,et al. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. , 2010, Biomaterials.
[140] Ick Chan Kwon,et al. Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[141] Abdullah-Al-Nahain,et al. Development of disulfide core-crosslinked pluronic nanoparticles as an effective anticancer-drug-delivery system. , 2011, Macromolecular bioscience.
[142] P. Sriamornsak,et al. Targeted therapy for cancer using pH-responsive nanocarrier systems. , 2012, Life sciences.
[143] R. Lerner,et al. Single-triggered trimeric prodrugs. , 2005, Angewandte Chemie.
[144] W. Pitt,et al. Ultrasonic activated drug delivery from Pluronic P-105 micelles. , 1997, Cancer letters.
[145] H. W. Scheeren,et al. Synthesis and characterization of biodegradable and thermosensitive polymeric micelles with covalently bound doxorubicin-glucuronide prodrug via click chemistry. , 2011, Bioconjugate chemistry.
[146] H. Hofmann,et al. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system , 2005 .
[147] S. Aoshima,et al. Synthesis of Stimuli-Responsive Polymers by Living Polymerization: Poly(N-Isopropylacrylamide) and Poly(Vinyl Ether)s , 2007 .